Six, 5to 10-week-old male Holstein calves were inoculated intratracheally with 5 x lo9 logarithmic growth phase Pasteurella haenzolytica biotype A serotype 1 (Al). Immunohistochemical techniques in conjunction with the use of monoclonal antibodies directed against P. haemolytica A 1 -derived lipopolysaccharide (LPS), capsular polysaccharide, and a polyclonal rabbit anti-leukotoxin antibody were used to localize their respective antigens in tissue sections of pneumonic lung at the light and electron microscopic levels. We found the following: 1) LPS, capsular polysaccharide, and leukotoxin were released into the inflammatory exudate; 2) LPS was found within the cytoplasm of neutrophils (located in the alveolus and alveolar wall), alveolar macrophages, endothelial cells, pulmonary intravascular macrophages, and on epithelial cell surfaces; 3) capsular polysaccharide was found in the alveolus and alveolar macrophages but not in cells of the alveolar wall; and 4) leukotoxin was associated with cell membranes of degenerating inflammatory cells located in the alveolus. This is the first study that demonstrates the presence of leukotoxin in the pulmonary inflammatory lesions caused by P. haemolytica A1 and implicates endotoxin as an important factor in the genesis of the pulmonary lesions.
Shipping fever or bovine pneumonic pasteurellosis is the disease responsible for the greatest economic loss in the North American cattle industry.s8 Pasteurella haernolytica biotype A serotype 1 (Al) is the bacterium most commonly isolated from this disease and is responsible for the characteristic fibrinous bronchopneumonia. 16,33,43~57 This bacterium produces several possible virulence factors. Of these factors, endotoxin and leukotoxin have been extensively studied.
The leukotoxin is a glycoprotein exotoxin produced only by logarithmic growth phase P. haemolytica. In vitro investigations indicate that leukotoxin is specific for ruminant neutrophils, monocytes/macrophages, and l y m p h o~y t e s .~,~~,~~ This toxin has a molecular weight of 105 kDa, as determined by sodium dodecyl sulfatepolyacrylamide gel electrophoresis; but, in the natural environment, it appears to exist in a multimeric state with an apparent molecular weight greater than 300 kDa.l0 The DNA sequence of the leukotoxin gene has been determined and found to have a large homology with the alpha-hemolysin of Escherichia coli. 32 The alpha-hemolysin of E. coli is a protein that forms pores in cell membranes allowing the transmembrane flux of calcium. 47 The lytic effect of leukotoxin has also been shown to depend on the presence of calcium in the medium. L 1~L 2 , 2 5 The possibility that leukotoxin interacts with parenchymal cells in the lung causing direct tissue injury has not been explored.
P. haemolytica A 1 is composed of 10-25% lipopolysaccharide, also known as e n d o t o~i n .~~,~~ Endotoxin from gram negative bacteria is capable of crossing the alveolar wall and interacting with cells and humoral mediator systems leading to numerous pathophysiologic alteration^.^^^^.^^.^^^^^,^^ Endotoxin, when given intravenously in sheep6 or exposed to bovine pulmonary artery endothelium in vit1-0,~~ causes physiologic and morphologic alterations in endothelial cells that lead to cell death. Although when given intravenously in rats the site of interaction of endotoxin in the lung has been inve~tigated,~l-*~,~~ the specific sites of endotoxin interaction in bovine pneumonic pasteurellosis have not.
The first objective of this study was to localize the cellular and subcellular site of interaction of endotoxin and leukotoxin in the lungs of calves experimentally infected with P. haemolytica A 1 by using immunohistochemical techniques at the light and electron microscopic levels. A second objective was to correlate the location of endotoxin and leukotoxin with the location of the bacterial cell by using a monoclonal antibody directed against the capsular polysaccharide of P. haemolytica A1 .
Material and Methods

Antibody production
The murine monoclonal antibodies (MAbs) IIB-6 and IIC-2 (both IgM isotypes) that reacted with Pasteurella haemolytica biotype A serotype 1 (A 1)-derived capsular polysaccharide and lipopolysaccharide (LPS), respectively, were used in this study. The production and characterization of these antibodies have been previously
The specificity of these MAbs was determined in an indirect enzyme-linked immunosorbent assay using highly purified capsular polysac~haride~~ and LPS42,56 derived from P. haemolytica A l . The exhausted culture media from these two hybridoma cell lines were stored at -70 C and used as primary antibodies in this study.
Monospecific antiserum directed against the leukotoxin was produced by immunizing pasteurella-free rabbits (Hazalton Research Products, Denver, PA) with the sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) purified leukotoxin. P. haemolytica A1 strain 12296 was grown to logarithmic growth phase in RPMI-1640 medium (Whittaker, M.A. Bioproducts, Walkersville, MA) supplemented with 1 mM glutamine for 4 h o~r s .~.~~ The bacteria were separated from the supernatant by centrifugation at 8,000 x g for 10 minutes at 4 C. The supernatant was filter sterilized by sequential filtration through 1.2-, 0.8-, and 0 . 4 5 -~m filters (Millipore Corp, Bedford MA) and then concentrated and dialyzed against distilled water using a spiral fiber apparatus (model CH25, Amicon Corp, Danvers, MA) equipped with a spiral cartridge (model SIY30, Amicon Corp, Danvers, MA). The retentate was lyophilized and stored in a desiccator at 4 C. This crude culture supernatant contained a mixture of leukotoxin, LPS, capsular polysaccharide, and unknown proteins. The protein concentration of this lyophilized material was determined using the method outlined by Bio-Rad laboratories (Richmond, CA). SDS-PAGE was performed, as described by Laemmli,3' by placing a volume of solubilized crude culture supernate equivalent to 20 pg of protein into each lane of a 6.5% polyacrylamide gel and electrophoresing at 15-20 mA for approximately 3 hours. The gel was stained with Coomassie blue (Fig. 1, lane 2 ) and the 105 kDa protein bands were cut out and frozen. To verify that the 105 kDa band was free of contaminants, a lane from a gel was cut out and stained for polysaccharide with Alcian blue (Aldrich, Milwaukee, WI). This staining showed that the capsular polysaccharide remained at the top of the gel (results not shown).
In addition, a second lane was stained for LPS, protein, and capsular polysaccharide using a modified silver stain2' (Fig.  1, lane 1) . The absence of contaminating protein was verified by electroeluting a cut out band and re-electrophoresing the eluted material (Fig. 1, lane 3) .
The frozen SDS-PAGE strips, containing the 105 kDa leukotoxin band, were ground up in sterile saline, and the resulting slurry was emulsified in an equal volume of Freund's complete adjuvant. Two rabbits were immunized subcutaneously with approximately 160 pg of protein per rabbit. Two other rabbits received only the polyacrylamide-105 kDa protein-saline mixture. The rabbits were immunized two more times at monthly intervals with a similar mixture, with the exception of the rabbits receiving the antigen-adjuvant mixture, in which Freund's incomplete adjuvant was used. Serum from all rabbits was obtained prior to the first immunization and 7 days after the last immunization. The specificity of this antiserum was determined by assessing its leukotoxin neutralizing abilitys4 and by Western blot analysisSZ ( Fig. 2 ) with crude lyophilized P. haemolytica A1 culture supernate as antigen. Antiserum from rabbits immunized with the leukotoxin-adjuvant or leukotoxin alone neutralized leukotoxin activity. The neutralization titer of the antiserum from rab- bits immunized with the leukotoxin-adjuvant mixture was 1:360, and the titer ofthe antiserum from rabbits immunized with the leukotoxin alone was 1:23.
Tissue preparation
Six, male, 5-to 10-week-old Holstein calves reared in isolation were inoculated intratracheally with 5 x lo9 logarithmic growth phase P. huemolyticu A1 suspended in 50 ml of phosphate buffered saline (PBS), pH 7.2, with 0.1% gelatin. Calves were euthanatized with a barbiturate overdose between 18 and 24 hours after inoculation. Representative samples of lesions were taken for light and electron microscopic immunohistochemistry. For electron microscopy, tissues were fixed separately in each of the following fixatives: periodatelysine-paraf~rmaldehyde,~~ 4.0% paraformaldehyde in 0.1 M phosphate buffer, 0.1 Yo glutaraldehyde plus 2.0% paraformaldehyde in 0.1 M phosphate buffer, and 20 mM ethylacetamide in 4.0% paraformaldehyde for 20 minutes followed by 1 .O% glutaraldehyde in 0.1 M phosphate buffer. For light microscopy, the fixatives used were modified m e t h a~a r n~~ and Bouin's in addition to those listed above. Tissues were fixed for 3 hours with agitation at 4 C in all fixatives except Bouin's, which was done at room temperature. Following a 4-hour wash with several changes of buffer, tissues for light microscopy were dehydrated in ethanol and embedded in paraffin. For electron microscopy, tissues were washed two times in 0.1 M phosphate buffer for 1 hour, followed by a 30-minute wash in buffer containing 0.5% NaBH, to block free aldehyde groups, followed by two buffer washes for 1 hour each. Tissues were then dehydrated and infiltrated in Lowicryl K4M (Polysciences, Womngton, PA) or L. R. White (Polysciences, Womngton, PA) resin. Tissues embedded in Lowicryl K4M were dehydrated in a graded series of dimethylformide (DMF) at progressively lower temperatures as follows: 30% DMF for 30 minutes at 4 C, 50% DMF for 30 minutes at 4 C, 70% DMF for 1 hour at -25 C, 90% DMF for 1 hour at -25 C, and 100% DMF for 3 x 30 minutes at -25 C. The tissues were then infiltrated with Lowicryl K4M, embedded in gelatin capsules, and polymerized under ultraviolet light for 5 days at -25 C. Tissues were processed into L. R. White at 22 C by first dehydrating them in a graded series of ethanol up to 80% and then infiltrating them with resin. The tissues were then embedded in gelatin capsules and polymerized at 50 C for 24 hours.
Immunohistochemistry
For light microscopy, tissue sections were deparaffinized, rehydrated, and washed in PBS. The tissues that had been fixed in glutaraldehyde had free aldehyde groups blocked with 0.5% NaBH, for 10 minutes followed by a PBS wash. Commercially available avidin-biotin immunoperoxidase (Vectastain, Vector Laboratories, Burlingame, CA) and immunogold-silver enhancement (AuroProbe LM and IntenSE M, Janssen Life Science Products, Beerse, Belgium) kits were used to localize the primary antibody in the tissue sections. For each kit, the manufacturer's staining procedure was followed. The secondary antibodies in both these kits were produced in goats and affinity purified. Normal goat serum was provided in each kit to use as a blocking agent. The undiluted, exhausted culture supernate from the IIB-6 or IIC-2 hybridoma cell lines were incubated on the tissue sections for 1 hour at room temperature in the primary antibody incubation step. The rabbit anti-leukotoxin serum from the leukotoxin-adjuvant immunized rabbit was diluted 1 : 800. The serum from the rabbit immunized without adjuvant 1 : 400 (as had been determined to be optimal in preliminary experiments) with PBS containing 0.5% bovine serum albumin (BSA) and incubated on the tissue sections for 2 hours at room temperature. The immunoperoxidase stain produces a red-brown reaction product, and the immunogold-silver stain produces a brown to black color at immunolabeled sites. Tissues were counterstained with Meyer's hematoxylin.
For electron microscopy, tissue sections were cut with a diamond knife and picked up on formvar-coated nickel grids.
A commercially available immunogold kit (AuroProbe EM, Janssen Life Science Products, Beerse Belgium), using 15 nm colloidal gold conjugated to affinity purified goat antirabbit antibody or antimouse IgM antibody, was used to localize the primary antibody on the tissue sections. The manufacturer's staining procedure was followed. Tissue sections were incubated on drops of undiluted IIC-2 or IIB-6 hybridoma culture supernate for 2 hours. The serum from the leukotoxin-adjuvant immunized rabbit was diluted 1:200 (as determined to be optimum) in PBS containing 0.5% BSA, 0.5% liquid gelatin, and 5% normal goat serum. Tissue sections were incubated for 3 hours on drops of diluted rabbit antileukotoxin serum. The secondary antibody was diluted 1 :20 and incubated on sections for 1 hour. All reagents used were those supplied by the manufacturer of the immunogold reagent.
Negative controls for the monoclonal antibodies consisted of deleting the primary antibody incubation step, using normal mouse serum in the primary antibody step, and/or an unrelated mouse IgM monoclonal antibody. For the rabbit anti-leukotoxin serum, the controls consisted of deleting this primary antiserum, using pre-immune rabbit serum, and absorbing the antiserum with the polyacrylamide gel band containing the 105 kDa leukotoxin protein. To rule out any nonspecific absorption by the polyacrylamide gel, a similar amount of polyacrylamide gel containing BSA was used to absorb a second aliquot of rabbit antiserum. Antiserum absorbed with the 105 kDa protein-polyacrylamide gel lost immunoreactivity in the tissue section, whereas the BSA-polyacrylamide gel protein absorbed serum did not.
Results
Antiserum from the rabbits immunized with either the leukotoxin-adjuvant or leukotoxin alone produced an identical staining pattern for leukotoxin immunoreactivity. The type of fixative used did not affect the staining pattern produced by the three primary antibodies but did affect the staining intensity. Similarly, the staining pattern produced by a primary antibody was the same with both the immunoperoxidase and immunogold-silver enhancement immunohistochemical techniques. The periodate-lysine-paraformaldehyde (PLP) and methacarn fixatives gave the most intense reaction with all three antibodies. The intensity of the IIC-2 (anti-lipopolysaccharide [LPS]) and IIB-6 (anti-capsular polysaccharide [capsule]) immunohistochemical staining was slightly less in tissues fixed with Bouin's, 4.0% paraformaldehyde (4-PF), 0.1 O/ o glutaraldehyde plus 2.0% paraformaldehyde (0.1 G-2PF), and ethylacetamide-paraformaldehyde-glutaraldehyde (EPG) . The leukotoxin immunoreactivity was more severely affected by these four fixatives. Bouin's fixative caused a moderate decrease; 4-PF and 0.1G-2PF caused a more severe decrease in reactivity; and EPG completely abolished leukotoxin immunoreactivity.
Light-microscopic immunohistochemistry
The anti-capsule, anti-LPS, and rabbit antiserum to the leukotoxin reacted in foci where there was severe inflammation (Fig. 3) . Neutrophils, alveolar macrophages, and parenchymal cells away from areas of severe inflammation did not stain. Edema in some alveoli had immunoreactivity to each of the primary antibodies.
The anti-LPS antibody had two distinct staining patterns. One type consisted of multifocal punctate foci of staining in alveolar wall cells and in inflammatory cells in alveolar lumens (Fig. 4) . The second type was a more diffuse staining of cells in the alveolar wall and lumen (Fig. 5 ). The punctate staining pattern was more common. There was also multifocal linear staining on alveolar surfaces and bronchiole epithelium with both the anti-LPS and anti-capsule antibodies (Figs. 6, 7) . These foci were more common in sections stained with the anti-capsule than with the anti-LPS antibody. Some neutrophils in bronchial lymph nodes had punctate foci of staining with the anti-LPS antibody but not with anti-capsule antibody. Inflammatory cells in the alveolar lumen were stained with the anti-capsule antibody ( Fig. 7) . In contrast to the anti-LPS antibody, the anti-capsule antibody did not stain cells within the alveolar septa. The arrow in Fig. 7 points to stained bacteria in edema fluid surrounded by a clear halo, similar to that seen at the ultrastructural level as seen in Fig. 17 . Bacteria were consistently stained with both the anti-capsule and anti-LPS antibodies.
The rabbit antiserum to the leukotoxin stained the cytoplasm and/or cell surface to degenerating inflammatory cells in the alveolus (Figs. 8, 9) . In some sections, there was multifocal linear staining of cells lining the alveolar capillaries ( Fig. 10 ). Normal sections of lung did not stain. Within the alveolus there were foci of bacteria that were stained with the rabbit antiserum, while other bacteria were not stained (Fig. 8 ). The staining pattern with the rabbit anti-leukotoxin was not as consistent as that of the anti-LPS and anticapsule in that the inflammatory foci that were morphologically similar did not always stain with the antileukotoxin antibody.
Immunoelectron microscopic findings
The PLP fixative was the only fixative used that adequately preserved leukotoxin immunoreactivity at the ultrastructural level; however, tissue morphology was poor. The 0.1 G-2PF fixative adequately preserved tissue morphology and immunoreactivity of the capsular polysaccharide and LPS.
The anti-LPS antibody reacted with the outer layer (cell wall) ofbacteria ( Fig. 1 la) , whereas the anti-capsule antibody had a more diffuse reactivity in the irregular zone of electron-dense material that surrounded some bacteria ( Figs. 1 1 b, 17) and was morphologically compatible with the bacterial capsule. The leukotoxin antiserum reacted with the bacterial cell in a variable pattern. Some bacteria did not have reactivity, whereas others had a few scattered gold spheres on the surface and within the bacterial cell.
The anti-LPS antibody localized LPS in the cytoplasm of neutrophils in the alveolus (Fig. 12 ), in the interstitium of the alveolar wall, and in alveolar capillaries ( Fig. 13 ). Alveolar macrophages had anti-LPS reactivity in phagolysosomes ( Fig. 12 ) and less frequently in the cytoplasm. Pulmonary intravascular Lung; calf. Intense staining of inflammatory foci was seen with each of the three antibodies. Immunoperoxidase, anti-lipopolysaccharide antibody stained, methacam-fixed tissue section.
Lung; calf. Note the punctate immunoreactivity for lipopolysacchande within cells in the alveolar wall and degenerate inflammatory cells in the alveolus. Immunoperoxidase, anti-lipopolysaccharide stained, periodate-lysine-paraformaldehyde-fixed tissue section.
Lung; calf. Note the more diffuse immunoreactivity of alveolar walls and inflammatory cells in the alveolus for lipopolysaccharide. Immunoperoxidase, anti-lipopolysaccharide stained, 0.1 Yo glutaraldehyde plus 2.0% paraformaldehydefixed tissue section. (Fig. 1 la) Bacteria in an alveolar lumen have lipopolysaccharide immunoreactivity of the outer layer (cell wall). Anti-lipopolysaccharide immunogold labeled, Lowi-cry1 embedded tissue. (Fig. 1 1 b ) Bacterium in an alveolus is surrounded by electron dense material whose appearance is morphologically compatible with that of the bacterium's capsule and has immunoreactivity for capsular polysaccharide. Anti-capsular polysaccharide immunogold labeled, Lowicryl embedded tissue. Bar = 0.5 pm. macrophages also had anti-LPS reactivity in localized foci in the cytoplasm (Figs. 14,16 ) and in phagocytosed neutrophils ( Fig. 1 5) . Alveolar capillary endothelial cells had anti-LPS reactivity in cytoplasmic foci (Fig. 15 ). Immunoreactivity with the anti-LPS antibody was not seen on cell surfaces.
The anti-capsule antibody localized capsular polysaccharide in phagolysosomes of alveolar macrophages and neutrophils in the alveolus. Immunoreactivity to capsule was not found in the cytoplasm of these cells nor in cells of the alveolar wall. In areas of alveolar edema, bacteria were frequently seen to be surrounded by a clear halo. This halo did not have capsular reactivity, but the bacterial cell surface and surrounding edema fluid did (Fig. 17) . Similar to the light microscopic observation, capsular polysaccharide immunoreactivity was found along alveolar surfaces.
Leukotoxin immunoreactivity was frequently found on membrane fragments of degenerating inflammatory cells in the alveolus (Fig. 18 ). Reactivity within cells of the alveolar capillary, similar to that seen at the light microscopic level, could not be found at the electron t Fig. 6 . Lung; calf. Immunoreactivity for capsular polysaccharide is along the bronchiole epithelial cell and alveolar surfaces. This staining pattern was seen less frequently with the anti-lipopolysaccharide antibody. Immunoperoxidase, anticapsular polysaccharide stained, periodate-lysine-paraformaldehyde-fixed tissue section. Fig. 7 . Lung; calf. Note the immunoreactivity for capsular polysaccharide of bacteria in alveolar edema (arrow), alveoli with diffuse staining of edema fluid, alveoli with edema but no staining (arrowhead), and staining along alveolar surfaces. Immunoperoxidase, anti-capsular polysaccharide stained, periodate-lysine-paraformaldehyde-fixed tissue section. Lung; calf. The degenerating inflammatory cells, in alveoli, have an intense immunoreactivity for leukotoxin. There are also bacteria that have leukotoxin immunoreactivity (arrowhead), while other bacteria lack staining (arrows) for leukotoxin immunoreactivity. Notice that the bacteria that lack leukotoxin immunoreactivity are basophilic. Immunoperoxidase, anti-leukotoxin serum stained, periodate-lysine-paraformaldehyde-fixed tissue section. Fig. 9 . Lung; calf. Note the immunoreactivity of degenerating leukocyte cell membranes for leukotoxin. Immunogoldsilver, anti-leukotoxin serum stained, methacam-fixed tissue section. Fig. 10 . Lung; calf. Note the multifocal immunoreactivity for leukotoxin of cells lining the alveolar capillary and immunoreactivity of alveolar edema and degenerating leukocytes in the alveolus. Immunogold-silver, anti-leukotoxin serum stained, methacam-fixed tissue section. 
Discussion
This study demonstrates that endotoxin from Pasteurella haemolytica biotype A serotype 1 (Al) was released into the inflammatory exudate in the alveolus and was found in alveolar macrophages, in neutrophils in the alveolus, and in neutrophils in the bronchial lymph nodes. Endotoxin also crossed the alveolar wall and was found within interstitial macrophages and neutrophils, endothelial cells, and pulmonary intravascular macrophages and neutrophils within the capillaries. Leukotoxin was also released into the alveolar exudate, and degenerating neutrophils and macrophages in the alveolus were found to have leukotoxin immunoreactivity. The capsular polysacchande was also released into the inflammatory exudate but did not cross the alveolar wall.
The ability of endotoxin to cross the alveolar wall has been demonstrated previously in rat^.^^,^^,^^,^^ These studies used either radiolabeled endotoxin given intravenously or immunohistochemical techniques following an intravenous injection of endotoxin to localize endotoxin in tissue sections. Endotoxin was demonstrated within neutrophils sequestered in capillaries and neutrophils phagocytosed by macrophages in the pulmonary capillary bed. Endotoxin was also found in the cytoplasm of endothelial cells, interstitial cells, alveolar macrophages, and, in one other study,22 in Type I epithelial cells. Endotoxin was found in alveolar macrophages as early as l hour after intravenous injection of endotoxin and persisted for up to 3 days in these cells. 22 In another study, endotoxin was similarly found in the cytoplasm of neutrophils that had been phagocytosed by Kupffer cells in the liver ofrats. 21 Endotoxin has also been found on the surface and within granules of rat platelets.40 Platelet uptake of endotoxin was not observed in this study.
The ability of endotoxin to rapidly cross the alveolar wall and interact with multiple cell types as well as humoral mediator systems3* has important implications in understanding the tissue injury that occurs in pneumonic pasteurellosis. Endotoxin can activate macrophages either directly4 or indirectly3* by activating complement in the or blood. These activated macrophages produce procoagulant, proinflammatory, and chemotactic mediators that initiate neutrophil infiltration and fibrin formation in the lung. 14, 39, 51, 55 The activation of complement and Hageman factor by endotoxin will also add to the generation of neutrophil chemotactic factors and fibrin formation. The interaction of endotoxin with endothelial cells can lead to cell activation and/or cell death.24 Endothelial cells can also be activated by cytokines produced by activated macrophages.13J4 These activated endothelial cells express neutrophil adhesion r n o l e~u l e s ,~~~~ and proinflammatory and procoagulant mediators, thus enhancing the sequestration of neutrophils and fibrin formation in the lung. 13,24,35,50 Endotoxin does not directly activate neutrophils, but in picogram doses it can prime neutrophils for increased oxidative metabolism and lysosomal enzyme release in response to a second agonist, such as the activated fifth component of complement.18J9 Thus, endotoxin can both prime neutrophils and generate the secondary stimulus. Studies with neutrophil-depleted calves have shown that neutrophils and their toxic oxygen radicals and enzymes are the primary mediators of the tissue damage that occurs in pneumonic p a s t e u r e l l~s i s .~~~~ One of the major objectives of this study was to determine if leukotoxin acted directly on cells of the alveolar wall. It was found that leukotoxin reacted pri-marily with the cell membrane of degenerating macrophages and leukocytes that were found in alveoli. Leukotoxin immunoreactivity was not observed on intact inflammatory cells. This may be because only in areas where there was sufficient leukotoxin concentration to cause rapid lysis of cells was there a high enough concentration of leukotoxin to be detected by immunohistochemistry. The multifocal leukotoxin immunoreactivity in cells lining alveolar capillaries suggests that pulmonary intravascular macrophages (PIM) may be the cells that were picking up the leukotoxin. In a previous morphologic study, the degenerative changes that leukotoxin produces in alveolar macrophages were not seen in PIM (unpublished observation). If leukotoxin is crossing the alveolar wall and reacting with PIM, it may be an inactive degradation product of the 105 kDa protein.
This in vivo observation supports in vitro experiments indicating that leukotoxin is specific for leuk o c y t e~.~,~~,~~ Thus, leukotoxin appears to function primarily as a defense mechanism for P. haemolytica and does not participate in direct lung injury. If leukotoxin does act as a membrane calcium pore forming protein,11~25~32 it may play a role in augmenting the inflam- matory response in the lung. The transmembrane flux of calcium into inflammatory cells has many eff e c t~.~~,~~,~~ It can 1) lead to the activation of phospholipases that release platelet activating factor and arachidonic acid from cell membranes with the subsequent formation of chemotactic and vasoactive lipids; 2) activate the respiratory burst and cause degranulation; and 3) participate in inducing the production of proinflammatory cytokines, such as interleukin-I and tumor necrosis factor. If uncontrolled calcium influx continues, cells die because of progressive degradation of cell membranes and proteins by phospholipases and pro tease^.^^ There is indirect evidence that suggests that calcium influx leading to cell activation followed by cell death may occur in pneumonic p a s t e u r e l l o~i s .~~~J~~~~ Bovine neutrophils and alveolar macrophages, when exposed to logarithmic growth phase P. haemolytica or bacterial culture supernate, undergo an initial respiratory burst followed by a precipitous decrease in oxidative metabolism, as measured by luminol-dependent chemilumines-~e n c e . * ,~J~-~~ Heat-lulled P. haemolytica and live P. multocida caused a more gradual and sustained rise in the respiratory burst. This suggests that leukotoxin is responsible for the observed respiratory burst pattern; therefore, in the early stages of the cytolytic process or at subcytolytic concentrations, leukotoxin may enhance the inflammatory response and subsequent tissue damage. Leukotoxin could also enhance tissue damage by lysing neutrophils and causing greater release of lysosomal enzymes.
The immunoreactivity of the bacterial cell to leukotoxin that was observed in this study has also been observed by others.lO The observation that some bacteria were stained while others were not may be explained by the fact that only logarithmic growth phase bacteria produce the toxin and thus would be expected to have immunoreactivity for leukotoxin. Stationary phase bacteria do not produce toxin and thus would not react with the rabbit anti-leukotoxin serum.
Capsular polysaccharide, and to a lesser degree LPS, was found on the surface of bronchiole and alveolar epithelium. Whether this is due to incorporation of these compounds into surfactant and mucous layers covering these cells, binding to the cell surface itself, or incorporation of these compounds into protein exudate laying on the surface of these cells could not be determined. Single bacteria were found adhering to these surfaces in a multifocal distribution but not in a linear pattern that would explain the immunohistochemical staining pattern; however, the LPS from P. haemolytica has been shown to form a stable complex with surfactant from sheep lung.7 This interaction may lead to a decrease in the surface tension reducing properties of surfactant.26 Increased alveolar surface tension potentiates pulmonary edema, atelectasis, and alveolar hemorrhage. Whether or not capsular polysaccharide has a similar effect on sufactant is not known.
Bacterial cells present in alveolar edema frequently had clear halos surrounding them. There may be two possible explanations for this observation. First, P. haemolytica produces neutral proteases4' that may degrade the protein in the edema. Second, P. haemolytica produces abundant capsular polysaccharide that collapses when the bacteria are dehydrated for routine electron These halos were seen, however, in the L. R. White embedded tissue that was only dehydrated through 80% alcohol. If the first hypothesis is true, this may be a protective mechanism for P. haemolytica. By degrading protein in proximity to the bacterial cell surface, the bacterium would be protected from the actions of antibodies and complement.
This in vivo study is the first to demonstrate the presence of leukotoxin in pulmonary inflammatory lesions in experimental P. haemolytica A 1 -induced pneumonia of cattle. This further supports an important role for leukotoxin in the pathogenesis of this disease. This study also raises interesting questions on the interaction of endotoxin with pulmonary intravascular macrophages, endothelial cells and neutrophils, and the role these interactions have in initiating the inflammatory response in the lung. Endotoxin may be the primary stimulus for inducing pulmonary inflammation, while leukotoxin may serve a protective function for the bacteria.
